新发急性髓系白血病中的复杂核型:典型与非典型亚型在分子和临床上的差异
该研究对160例临床特征明确的新发急性髓系白血病患者进行81个白血病/癌症相关基因的突变分析,其中136例为≥3种不平衡染色体异常(96例典型复杂核型、40例非典型复杂核型),24例为≥1种平衡异常合并≥2种不平衡异常。非典型复杂核型患者TP53突变较少,PHF6、FLT3-TKD、MED12、NPM1突变较多,且更年轻、白细胞更高、骨髓和外周血原始细胞比例更高、完全缓解率更高、总生存更长。
要点
- 非典型复杂核型较典型复杂核型TP53突变少(P<0.001),PHF6、FLT3-TKD、MED12、NPM1突变多。
- 非典型复杂核型患者更年轻(P=0.007),白细胞更高(P=0.001),骨髓(P<0.001)和外周血(P=0.006)原始细胞比例更高。
- 非典型复杂核型完全缓解率更高(P=0.02),总生存更长(P<0.001)。
核心结论
- 非典型与典型复杂核型急性髓系白血病构成不同的疾病亚型。
- 在典型和非典型复杂核型急性髓系白血病中均识别出分子和临床特征不同的较小患者亚群。
研究设计与样本
- 对160例临床特征明确的新发急性髓系白血病患者进行81个白血病/癌症相关基因的突变状态分析。
- 136例为≥3种不平衡染色体异常,其中96例典型复杂核型、40例非典型复杂核型;24例为≥1种平衡异常合并≥2种不平衡异常。
主要发现
- 非典型复杂核型较典型复杂核型TP53突变较少(P<0.001),PHF6突变较多(P=0.008),FLT3-TKD突变较多(P=0.02),MED12突变较多(P=0.02),NPM1突变较多(P=0.02)。
- 非典型复杂核型患者较典型复杂核型更年轻(P=0.007),白细胞更高(P=0.001),骨髓原始细胞比例更高(P<0.001),外周血原始细胞比例更高(P=0.006)。
- 非典型复杂核型患者较典型复杂核型完全缓解率更高(P=0.02),总生存更长(P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Complex karyotype (CK) with ≥ 3 abnormalities is detected in 10-12% of patients with acute myeloid leukemia (AML) and associated with poor prognosis. The most common unbalanced abnormalities found in CK result in loss of material from the 5q, 7q, and/or 17p chromosome arms. The presence of 5q, 7q, and/or 17p abnormalities denotes typical CK and their absence denotes atypical CK. Since molecular features of CK-AML are not well characterized, we investigated mutational status of 81 leukemia/cancer-associated genes in 160 clinically well-characterized patients. They included 136 patients with ≥ 3 exclusively unbalanced chromosome abnormalities, 96 of whom had a typical CK and 40 atypical CK, and 24 patients with ≥ 1 balanced abnormality in addition to ≥ 2 unbalanced ones. Patients with atypical CK-AML differed from those with typical CK-AML: they carried TP53 mutations less often (P < 0.001) and more often PHF6 (P = 0.008), FLT3-TKD (P = 0.02), MED12 (P = 0.02), and NPM1 (P = 0.02) mutations. They were younger (P = 0.007), had higher WBC (P = 0.001) and percentages of marrow (P < 0.001) and blood (P = 0.006) blasts, higher complete remission rates (P = 0.02), and longer overall survival (P < 0.001), thus indicating that atypical and typical CK-AMLs constitute distinct disease subtypes. We also identified smaller patient subsets within both typical and atypical CK-AML that differed molecularly and clinically.
引用
- Mrózek K, Eisfeld AK, Kohlschmidt J, et al. Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically. Leukemia. 2019. PMID: 30737482. doi:10.1038/s41375-019-0390-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。